Increasing trimethylamine N-oxide levels as a predictor of early neurological deterioration in patients with acute ischemic stroke

References

• Liu M, Wu B, Wang WZ, et al. Stroke in China: epidemiology, prevention, and management strategies. Lancet Neurol. 2007;6(5):456–464.
   PubMed Web of Science ®Google Scholar
• Zhao D, Liu J, Wang W, et al. Epidemiological transition of stroke in China: twenty-one-year observational study from the Sino-MONICA-Beijing Project. Stroke. 2008;39(6):1668–1674.
   PubMed Web of Science ®Google Scholar
• Zhang X, Sun Z, Ding C, et al. Metabolic syndrome augments the risk of early neurological deterioration in acute ischemic stroke patients independent of inflammatory mediators: a hospital-based prospective study. Oxidative medicine and cellular longevity. 2016. 2016.
   Google Scholar
• Sun W, Liu W, Zhang Z, et al. Asymmetrical cortical vessel sign on susceptibility‐weighted imaging: a novel imaging marker for early neurological deterioration and unfavorable prognosis. Eur J Neurol. 2014;21(11):1411–1418.
   PubMed Web of Science ®Google Scholar
• Yi X, Han Z, Zhou Q, et al. 20-Hydroxyeicosatetraenoic acid as a predictor of neurological deterioration in acute minor ischemic stroke. Stroke. 2016;47(12):3045–3047.
   PubMed Web of Science ®Google Scholar
• Seners P, Turc G, Oppenheim C, et al. Incidence, causes and predictors of neurological deterioration occurring within 24 h following acute ischaemic stroke: a systematic review with pathophysiological implications. J Neurol Neurosurg Psychiatry. 2015;86(1):87–94.
   PubMed Web of Science ®Google Scholar
• Alawneh J, Moustafa R, Baron J. Hemodynamic factors and perfusion abnormalities in early neurological deterioration. Stroke. 2009;40(6):e443–50.
   PubMed Web of Science ®Google Scholar
• Koeth R, Wang Z, Levison B, et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med. 2013;19(5):576–585.
   PubMed Web of Science ®Google Scholar
• Wang Z, Klipfell E, Bennett B, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 2011;472(7341):57–63.
   PubMed Web of Science ®Google Scholar
• Tang W, Wang Z, Levison B, et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med. 2013;368(17):1575–1584.
   PubMed Web of Science ®Google Scholar
• Nie J, Xie L, Zhao B, et al. Serum trimethylamine N-Oxide concentration is positively associated with first stroke in hypertensive patients. Stroke. 2018;49(9):2021–2028.
   PubMed Web of Science ®Google Scholar
• Haghikia A, Li X, Liman T, et al. Gut microbiota-dependent trimethylamine N-Oxide predicts risk of cardiovascular events in patients with stroke and is related to proinflammatory monocytes. Arterioscler Thromb Vasc Biol. 2018;38(9):2225–2235.
   PubMed Web of Science ®Google Scholar
• Tang W, Wang Z, Kennedy D, et al. Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease. Circ Res. 2015;116(3):448–455.
   PubMed Web of Science ®Google Scholar
• Senthong V, Wang Z, Fan Y, et al. Trimethylamine N-Oxide and mortality risk in patients with peripheral artery disease. J Am Heart Assoc. 2016;5(10):e004237. pii.
   PubMed Web of Science ®Google Scholar
• Bennett B, de Aguiar Vallim T, Wang Z, et al. Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation. Cell Metab. 2013;17(1):49–60.
   PubMed Web of Science ®Google Scholar
• Zhu W, Gregory J, Org E, et al. Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk. Cell. 2016;165(1):111–124.
   PubMed Web of Science ®Google Scholar
• Adams HPJ, Bendixen B, Kappelle L, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke. 1993;24(1):35–41.
   PubMed Web of Science ®Google Scholar
• Wang Z, Klipfell E, Bennett B, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 2011;472(4371):57–63.
   PubMed Web of Science ®Google Scholar
• Wang Z, Levison B, Hazen J, et al. Measurement of trimethylamine-N-oxide by stable isotope dilution liquid chromatography tandem mass spectrometry. Anal Biochem. 2014;455:35–40.
   PubMed Web of Science ®Google Scholar
• Siegler J, Martin-Schild S. Early neurological deterioration (END) after stroke: the END depends on the definition. Int J Stroke. 2011;6(3):211–212.
   PubMed Web of Science ®Google Scholar
• Eckburg P, Bik E, Bernstein C, et al. Diversity of the human intestinal microbial flora. Science. 2005;308(5728):1635–1638.
   PubMed Web of Science ®Google Scholar
• Gholizadeh P, Mahallei M, Pormohammad A, et al. Microbial balance in the intestinal microbiota and its association with diabetes, obesity and allergic disease. Microb Pathog. 2019;127:48–55.
   PubMed Web of Science ®Google Scholar
• Ma J, Li H. The role of gut microbiota in atherosclerosis and hypertension. Front Pharmacol. 2018;9:1082.
   PubMed Web of Science ®Google Scholar
• Zeisel S, Warrier M. Trimethylamine N-oxide, the microbiome, and heart and kidney disease. Annu Rev Nutr. 2017;37:157–181.
   PubMed Web of Science ®Google Scholar
• Kwon H, Lee Y, Bae H, et al. Homocysteine as a predictor of early neurological deterioration in acute ischemic stroke. Stroke. 2014;45(3):871–873.
   PubMed Web of Science ®Google Scholar
• Martin A, Price C. A systematic review and meta-analysis of molecular biomarkers associated with early neurological deterioration following acute stroke. Cerebrovasc Dis. 2018;46(5–6):230–241.
   PubMed Web of Science ®Google Scholar
• Dinan T, Cryan J. Gut instincts: microbiota as a key regulator of brain development, ageing and neurodegeneration. J Physiol. 2017;595(2):489–503.
   PubMed Web of Science ®Google Scholar
• Boini K, Hussain T, Li P, et al. Trimethylamine-N-Oxide instigates NLRP3 inflammasome activation and endothelial dysfunction. Cell Physiol Biochem. 2017;44(1):152–162.
   PubMedGoogle Scholar
• Siniscalchi A, Gallelli L, Malferrari G, et al. Cerebral stroke injury: the role of cytokines and brain inflammation. J Basic Clin Physiol Pharmacol. 2014;25(2):131–137.
   PubMedGoogle Scholar
• Xu R, Wang Q. Towards understanding brain-gut-microbiome connections in Alzheimer’s disease. BMC Syst Biol. 2016;10(Suppl 3):3.
   PubMed Web of Science ®Google Scholar
• Zhu W, Buffa J, Wang Z, et al. Flavin monooxygenase 3, the host hepatic enzyme in the metaorganismal trimethylamine N-oxide-generating pathway, modulates platelet responsiveness and thrombosis risk. J Thromb Haemost. 2018;16(9):1857–1872.
   PubMed Web of Science ®Google Scholar
• Yi X, Lin J, Wang C, et al. A comparative study of dual versus monoantiplatelet therapy in patients with acute large-artery atherosclerosis stroke. J Stroke Cerebrovasc Dis. 2014;23(7):1975–1981.
   PubMed Web of Science ®Google Scholar